[Ticlopidine-induced pancytopenia: therapy of agranulocytosis with granulocyte colony stimulating factor].
Schneider
A W
AW
Medizinische Kliniken des St.-Katharinen-Krankenhauses Frankfurt/Main.
Fechler
L
L
Gilfrich
H J
HJ
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced* / Q000628:therapy; D001707:Biopsy, Needle; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage*; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy*; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D013988:Ticlopidine / Q000009:adverse effects* / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D016179:Granulocyte Colony-Stimulating Factor; D013988:Ticlopidine
Ticlopidin-induzierte Panzytopenie: Therapie der Agranulozytose mit granulozytenkoloniestimulierendem Faktor.